What a consultant pharmacist actually does at a surgery center (and why the quarterly visit is the whole ballgame)

Most surgery center administrators meet their consultant pharmacist twice. Once when the contract is signed, and once when a surveyor asks who is responsible for pharmaceutical services. I'd like to change that, because the quarterly visit is where the whole thing is decided.

Here's the scene I keep walking into. It's 6:40 on a turnover morning. Pre-op is stocking. Anesthesia is pulling drugs for the first case. Somebody's refrigerator log has a gap from the weekend. Nobody is doing anything wrong on purpose. And if a surveyor walked in right then and asked, "Walk me through what happens when your narcotic count is off," the room would get quiet. My job is to make sure it doesn't.

Where the role comes from (federal)

The Medicare Conditions for Coverage for ambulatory surgical centers say the center "must provide drugs and biologicals in a safe and effective manner, in accordance with accepted professional practice, and under the direction of an individual designated responsible for pharmaceutical services" (42 CFR 416.48). The standard underneath it requires drugs to be prepared and administered according to established policies and acceptable standards of practice, adverse reactions reported to the responsible physician and documented, blood and blood products administered only by physicians or registered nurses, and oral orders followed by a written order signed by the prescribing physician (42 CFR 416.48(a)).

Notice what the regulation does not say. It doesn't say "pharmacist." CMS's own surveyor guidance (State Operations Manual, Appendix L, tag Q-0180) says the center must designate a specific licensed healthcare professional to direct pharmaceutical services, that the person must be routinely present when the center is open, and that "ideally the ASC should have available a pharmacist who provides oversight or consultation," which the guidance calls not required by the regulation unless state law reserves an activity to a pharmacist. The same guidance tells surveyors what to ask: how often that individual is on site, for how long, and what documentation shows active direction and oversight. That is the whole game. A designated name with no visits and no paper trail fails the question; a consultant pharmacist who comes on site on a schedule and leaves a signed report answers it.

Where the role comes from (California)

First, a correction to something I hear constantly: most surgery centers in California are not licensed by the Board of Pharmacy, and they don't have to be. Business and Professions Code section 4190 is written as a permission, not a mandate. A clinic licensed by the Board "may purchase drugs at wholesale" for its patients, and "no clinic shall be entitled to the benefits of this section until it has obtained a license." A center that doesn't buy drugs at wholesale as an organization has no reason to hold one, and section 4190(f) preserves the physician's own authority to prescribe, dispense, administer, and furnish. In my experience the majority of accredited centers run that way, which means their consultant pharmacist relationship comes from Medicare and their accreditor, not from a Board license.

If your center does hold a section 4190 license (a surgical clinic licensed under Health and Safety Code 1204(b)(1), an accredited outpatient setting under Health and Safety Code 1248, or a Medicare-certified ASC that chose to license), the relationship becomes statutory. Section 4192 requires the clinic to retain a consulting pharmacist who:

• approves the clinic's policies and procedures together with the professional director and the administrator (section 4191 lists what those policies must cover: inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation);

• visits the clinic at least quarterly, more often by mutual agreement;

• provides a written quarterly certification of compliance or non-compliance with the article, with any recommended corrective actions, kept on file for three years;

• signs, with the professional director, the Surgical Clinic Self-Assessment before July 1 of every odd-numbered year, under penalty of perjury. The Board can act on uncorrected deficiencies the form identifies.

Two more statutory facts live nearby for licensed centers. Under section 4190(c), a licensed surgery clinic may dispense only for the control of pain and nausea, and no more than a 72-hour supply; everything else is administration. Under section 4190(b), records of drugs purchased, administered, and dispensed are kept for three years.

Either way you got here, the quarterly visit does the same job. For a licensed center it is the statutory floor. For an accredited, unlicensed center it is the evidence a surveyor is told to ask for: how often, for how long, and where is the documentation. A signed quarterly report answers all three, and it tells whoever is asking whether anyone has actually been looking.

What a quarterly visit actually looks like

This is what I do on site. Not by phone, and not by a checklist emailed to the nurse manager.

Walk the drug's path. Receiving to storage to preparation to administration to waste to destruction. At every step I want the record and the practice to match. Invoices matched to what's on the shelf. Refrigerator and room temperature logs complete, with the action taken on any excursion written down, not just the number. Controlled substances secured, counted, and reconciled, with waste witnessed and reconciled against what was drawn.

Look at what's drawn ahead. Syringes prepared in advance are the most common labeling gap I find, and the policy usually says something different from what the anesthesia cart does. The fix is a label standard the staff can actually follow at 6:40 a.m., not a paragraph in a manual.

Open the emergency kits. Crash cart and emergency drug supplies checked, sealed, and in date, with the log to prove it.

Read the policies against the room. If the policy says "pharmacist verifies" in a center where the pharmacist visits quarterly, the policy is describing a center that doesn't exist. Surveyors notice. We rewrite it to describe what the center really does, then hold the center to that.

Talk to the people. The surveyor will interview your circulator, your pre-op nurse, and your anesthesia provider. I ask the same questions first. What do you do when a count is off? Where's the temperature excursion procedure? Who signs waste? Their answers tell me whether the policy is on paper or in practice.

Leave a scored report the same week. Findings with a severity, an owner, and a due date. Each finding stays open until it's closed, and the next visit starts by checking the last report. Then the quarterly certification gets signed for the file.

The three findings I write most

Different centers, same three.

1. The policy manual and the practice disagree. Usually the manual was written for a different building.

2. Controlled substance waste is documented but never reconciled against what was drawn, so a discrepancy can hide for a quarter.

3. Temperature logs with gaps and no excursion response. A gap is a finding. A gap plus no procedure for what to do about it is a bigger one.

None of these are exotic. All of them are on the survey.

What to ask a consultant pharmacist before you sign

• Do you come on site, and how often? Surveyors are told to ask exactly that. Ask what "visit" means.

• What do I receive after a visit, and when?

• Do you track findings to closure, or just list them?

• Will you sign the quarterly certification and the self-assessment, and what will you need from us first?

• Do you handle the 4190 license itself, and changes of ownership? A license is one project. Keeping it is a standing one. It helps when the same person does both.

If you want to see what our version of the quarterly visit looks like, the surgery center consulting page walks through it. If you'd rather just talk, book a 30-minute call and bring your last survey report. I'll tell you what I'd look at first.

Sources

• 42 CFR 416.48 (Medicare Conditions for Coverage for ASCs: pharmaceutical services) and CMS State Operations Manual, Appendix L, tag Q-0180 (interpretive guidelines and survey procedures for 416.48).

• Business and Professions Code sections 4190, 4191, and 4192 (clinic license for surgical clinics, accredited outpatient settings, and Medicare-certified ASCs; policies; consulting pharmacist duties and the self-assessment).

• Health and Safety Code sections 1204(b)(1) and 1248 (surgical clinic and outpatient setting definitions).

General information from a consultant pharmacist, not legal advice. Your accreditation standards and your center's license terms control.